Cohen Kenneth M

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

MabVax Therapeutics Holdings Inc (MBVXQ)

Transaction date 24 Jan 2018

Sale

Price

175.76

Quantity 32,448 -30.7%

Value US$3,909,215

Comments Filing

MabVax Therapeutics Holdings Inc (MBVXQ)

Transaction date 23 Jan 2018

Sale

Price

218.32

Quantity 69,962 -44.4%

Value US$2,611,034

Comments Filing

MabVax Therapeutics Holdings Inc (MBVXQ)

Transaction date 17 Aug 2016

Purchase

Price

277.35

Quantity 71,448

Value US$1,099,656

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2018-01-24	2018-01-24	MabVax Therapeutics Holdings Inc (MBVXQ)	S Sale	32,448 -30.7% 175.76 US$3,909,215	32,448 -30.7%	175.76	US$3,909,215
2018-01-24	2018-01-23	MabVax Therapeutics Holdings Inc (MBVXQ)	S Sale	69,962 -44.4% 218.32 US$2,611,034	69,962 -44.4%	218.32	US$2,611,034
2016-08-19	2016-08-17	MabVax Therapeutics Holdings Inc (MBVXQ)	B Purchase	71,448 277.35 US$1,099,656	71,448	277.35	US$1,099,656